Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.
BACKGROUND
We recently showed that Bifidobacterium animalis is more prevalent within the colons of interleukin (IL)-10-deficient (-/-) mice than in wildtype (WT) animals colonized with the same specific pathogen-free (SPF) fecal contents. Here we tested the ability of this organism to cause T-cell-mediated intestinal inflammation by introducing it into germ-free (GF) IL-10-/- mice.


METHODS
GF IL-10-/- or WT mice were monoassociated with Bifidobacterium animalis subsp. animalis ATCC (American Type Culture Collection, Manassas, VA) 25527(T) or with B. infantis ATCC 15697(T). Inflammation was measured by blinded histologic scores of the duodenum, cecum, and colon and by spontaneous secretion of IL-12/IL-23 p40 from colonic explants. Bacterial antigen-specific CD4(+) mesenteric lymph node (MLN) T-cell recall responses were measured in response to antigen-presenting cells (APC) pulsed with bacterial lysates.


RESULTS
B. animalis caused marked duodenal inflammation and mild colitis in monoassociated IL-10-/- mice, whereas the intestinal tracts of WT animals remained free of inflammation. B. infantis colonization resulted in mild inflammation in the duodena of IL-10-/- mice. CD4(+) MLN T cells from B. animalis monoassociated IL-10-/- mice secreted high levels of IFN-gamma and IL-17 in response to B. animalis lysate. B. animalis equally colonized the different intestinal regions of WT and IL-10-/- mice.


CONCLUSIONS
B. animalis, a traditional probiotic species that is expanded in experimental colitis in this model, induces marked duodenal and mild colonic inflammation and TH1/TH17 immune responses when introduced alone into GF IL-10-/- mice. This suggests a potential pathogenic role for this commensal bacterial species in a susceptible host.
Moran
James P
JP
Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina, USA.
Walter
Jens
J
Tannock
Gerald W
GW
Tonkonogy
Susan L
SL
Sartor
R Balfour
RB
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D039941:Bifidobacteriales Infections / Q000150:complications* / Q000276:immunology / Q000473:pathology; D001644:Bifidobacterium / Q000276:immunology*; D003092:Colitis / Q000276:immunology / Q000382:microbiology* / Q000473:pathology; D003713:Dendritic Cells / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D004195:Disease Models, Animal; D004382:Duodenitis / Q000276:immunology / Q000382:microbiology* / Q000473:pathology; D000939:Epitopes / Q000276:immunology; D016753:Interleukin-10 / Q000235:genetics / Q000276:immunology*; D018664:Interleukin-12 / Q000276:immunology; D053759:Interleukin-23 / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D008817:Mice, Mutant Strains; D012720:Severity of Illness Index; D018417:Th1 Cells / Q000276:immunology / Q000382:microbiology / Q000473:pathology
D000942:Antigens, Bacterial; D000939:Epitopes; D053759:Interleukin-23; D016753:Interleukin-10; D018664:Interleukin-12